OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup. The new venture could be valued at $2 billion, reflecting strong investor interest in AI's potential for life sciences breakthroughs. This development highlights a growing trend of AI expertise being channeled into specialized fields like pharmaceuticals.
Opening Kapyn…